2022 Volume 12 Issue 1 Pages 41-49
Coronavirus disease 2019 (COVID-19) is the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which appeared in Wuhan, China, in December 2019 and has continued to spread rapidly around the world. Although the majority of COVID-19 in children are mild, there are many important unanswered questions. And the influence of COVID-19 against pediatric rheumatic diseases is also limited. On the other hand, after COVID-19, a new disease with multisystem inflammatory syndrome in children (MIS-C/PIMS) was reported. In this article, this review highlights the current findings on COVID-19, pediatric rheumatic diseases and medical care.